Best Relative Performance in the Life Sciences Tools & Services Industry Detected in Shares of QIAGEN (QGEN, LIFE, WAT, BRKR, CRL)

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

QIAGEN (NASDAQ:QGEN) ranks first with a gain of 1.17%; Life Technologies (NASDAQ:LIFE) ranks second with a gain of 1.15%; and Waters (NYSE:WAT) ranks third with a gain of 0.99%.

Bruker (NASDAQ:BRKR) follows with a gain of 0.37% and Charles River Laboratories (NYSE:CRL) rounds out the top five with a gain of 0.09%.

QIAGEN N.V. provides technologies for separating and purifying DNA and RNA. The Company's portfolio consists of consumable products for nucleic acid separation, purification, and handling and nucleic acid amplification, as well as automated instrumentation and related services.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

HEICO Bested Estimates, Rose 22.1% Year-...

HEICO (NYSE:HEI) reported Q1 EPS $0.45, better than analyst estimates of $0.44 per shar ...

Jack in the Box Bested Estimates For Q1 ...

Jack in the Box (NASDAQ:JACK) reported Q1 EPS $0.25, better than analyst estimates of $ ...

Limited Tops Estimates For Q4, Rose 1.7%...

Limited (NYSE:LTD) reported Q4 EPS of $1.50, better than analyst estimates of $1.46 per ...

Loopnet Bested Estimates For Q4, Rose 10...

Loopnet (NASDAQ:LOOP) reported Q4 EPS of $0.11, better than analyst estimates of $0.08 ...

Synopsys Tops Estimates For Q1, Rose 16....

Synopsys (NASDAQ:SNPS) reported Q1 EPS of $0.56, better than analyst estimates of $0.52 ...

Hewlett-Packard Reports Mixed Earnings F...

Hewlett-Packard (NYSE:HPQ) reported Q1 EPS of $0.92, better than analyst estimates of $ ...

Caribou Coffee Bested Estimates For Q4, ...

Caribou Coffee (NASDAQ:CBOU) reported Q$ EPS of $0.14, better than analyst estimates of ...

Fluor Reports Mixed Earnings For Q4, Ros...

Fluor (NYSE:FLR) reported Q4 EPS of $0.90, better than analyst estimates of $0.82 per s ...